Schizandrol increases HSL phosphorylation, reduces glycerolipid levels and increases fatty acid oxidation gene expressions in the subcutaneous adipocytes. Adding schizandrol to PEAs prevent the upregulation of cortisol by reducing oxidative stress, thus preventing the negative side effects of noradrenaline and dopamine.